On the GARDP website, navigate to their 2024-2028 strategy page. Identify the core purpose of GARDP's unique antibiotic R&D partnership model. Then, locate the section on maximizing impact and list the three main criteria that guide GARDP's disease area strategy, summarizing each one.
Navigate to gardp.org. From the homepage, navigate to the 'GARDP Strategy 2024-2028' page (e.g., via 'Our work' -> 'Our strategy'). Identify the core purpose of GARDP's unique antibiotic R&D partnership model as stated on the page. Scroll down the page to find the section titled 'Maximizing impact'. Identify and list the three criteria guiding GARDP's disease area strategy and their brief summaries. Present the identified purpose and the listed criteria with their summaries.
Successfully navigate to the 'GARDP Strategy 2024-2028' page. Accurately state the core purpose of GARDP’s unique antibiotic R&D partnership model as: 'enabling the right antibiotic treatments to be developed and made available to people who need them'. Accurately list the three main criteria for GARDP's disease area strategy: - Prioritizes serious bacterial infections and sepsis (including neonatal sepsis) and sexually transmitted infections (with a focus on gonorrhoea). - Targets WHO priority pathogens that are responsible for particularly deadly and debilitating drug-resistant infections. - Concentrates its efforts on populations who are disproportionately affected by drug resistance—like newborns, children and women, particularly in low- and middle-income countries.